Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12,498	7,561	6,371	27,800	15,001
Short-Term Investments	-	-	-	110	30
Cash & Short-Term Investments	12,498	7,561	6,371	27,910	15,031
Cash Growth	65.29%	18.68%	-77.17%	85.69%	-28.13%
Accounts Receivable	36,699	24,605	29,440	19,649	22,199
Other Receivables	1,094	1,008	302.04	638.16	398.12
Receivables	37,794	25,613	29,742	20,287	22,597
Inventory	46,726	67,777	68,494	45,998	42,790
Prepaid Expenses	4,127	3,406	4,579	3,743	7,237
Other Current Assets	909.02	688.31	998.16	82.57	12,908
Total Current Assets	102,055	105,045	110,184	98,021	100,563
Property, Plant & Equipment	115,076	123,138	125,960	131,481	141,893
Long-Term Investments	197,223	77,054	75,240	2,549	3,262
Goodwill	-	-	1,217	1,217	1,217
Other Intangible Assets	554.34	168.28	58.95	99.11	199.79
Long-Term Accounts Receivable	-0	0	-0	-0	-0
Long-Term Deferred Charges	44.86	164.25	283.64	403.04	522.43
Other Long-Term Assets	4,610	3,866	1,174	888.54	680.57
Total Assets	419,563	309,436	314,118	234,658	248,338
Accounts Payable	11,950	7,442	17,049	13,774	11,808
Accrued Expenses	4,908	4,355	3,594	3,145	2,721
Short-Term Debt	105,890	97,262	69,461	59,064	61,751
Current Portion of Long-Term Debt	9,993	-	4,000	5,333	5,333
Current Portion of Leases	692.76	428.66	287.62	336.45	348.65
Current Income Taxes Payable	-	-	376.36	-	-
Current Unearned Revenue	3,201	3,201	3,201	3,500	3,500
Other Current Liabilities	69,620	15,653	11,608	10,316	59,689
Total Current Liabilities	206,255	128,341	109,578	95,469	145,152
Long-Term Debt	8,699	9,980	-	4,000	9,333
Long-Term Leases	1,324	191.33	167.18	191.02	262.15
Long-Term Deferred Tax Liabilities	33,629	9,874	9,760	-	-
Other Long-Term Liabilities	13,487	16,938	17,078	25,139	25,903
Total Liabilities	270,225	171,764	146,395	135,248	190,381
Common Stock	6,212	5,706	5,706	5,706	5,706
Additional Paid-In Capital	192,801	167,553	209,114	209,542	167,980
Retained Earnings	-228,091	-133,289	-101,537	-106,024	-104,359
Treasury Stock	-	-	-	-812.88	-812.88
Comprehensive Income & Other	178,417	97,702	54,440	-9,001	-10,557
Total Common Equity	149,338	137,672	167,723	99,410	57,957
Shareholders' Equity	149,338	137,672	167,723	99,410	57,957
Total Liabilities & Equity	419,563	309,436	314,118	234,658	248,338
Total Debt	126,598	107,863	73,916	68,925	77,029
Net Cash (Debt)	-114,100	-100,301	-67,545	-41,015	-61,998
Net Cash Per Share	-9553.71	-8788.83	-5344.94	-3597.74	-5438.33
Filing Date Shares Outstanding	12.42	11.41	11.41	11.4	11.4
Total Common Shares Outstanding	12.42	11.41	11.41	11.4	11.4
Working Capital	-104,200	-23,296	606.75	2,552	-44,589
Book Value Per Share	12020.68	12063.41	14696.64	8720.06	5083.88
Tangible Book Value	148,783	137,504	166,448	98,094	56,541
Tangible Book Value Per Share	11976.05	12048.67	14584.86	8604.64	4959.63
Land	16,281	16,281	17,286	17,008	17,024
Buildings	81,462	88,069	88,567	88,891	88,874
Machinery	108,063	104,638	101,589	102,952	90,469
Construction In Progress	13,857	17,810	16,474	15,952	28,846

Source: S&P Global Market Intelligence. Standard template. Financial Sources.